Effect of previous hormone replacement therapy on endometrial polyps during menopause

The aim of this study was to evaluate the effect of hormone replacement therapy (HRT) on the expression of Ki-67, bcl-2 and c-erb.B2 in endometrial polyps during menopause. Sixteen patients using HRT and 24 untreated controls with endometrial polyps were enrolled in this study. Polypectomy was carried out by hysteroscopy. The presence of c-erb.B2, bcl-2 and Ki-67 expression was determined by immunohistochemistry. HRT was found to decrease Ki-67 and bcl-2 expression in endometrial polyps without affecting the c-erb.B2 staining reaction. HRT may cause endometrial polyp involution by decreasing proliferation and stimulating apoptosis.

[1]  I. Nofroni,et al.  Hysteroscopic findings in postmenopausal abnormal uterine bleeding: a comparison between HRT users and non-users. , 2002, Maturitas.

[2]  S. Granberg,et al.  The effects of oral estriol on the endometrium in postmenopausal women. , 2002, Maturitas.

[3]  P. Bhal,et al.  Role of hysteroscopy in the detection and extraction of endometrial polyps: results of a prospective study. , 2002, American journal of obstetrics and gynecology.

[4]  V. Abeler,et al.  Dissociated Expression of Bcl-2 and Ki-67 in Endometrial Lesions: Diagnostic and Histogenetic Implications , 2002, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[5]  I. Timor-Tritsch,et al.  Evaluation of endometrial polyps. , 2002, American journal of obstetrics and gynecology.

[6]  H. Maia,et al.  Proliferation profile of endometrial polyps in post-menopausal women. , 2001, Maturitas.

[7]  T. Maruo,et al.  Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium. , 2001, Human reproduction.

[8]  H. Maia,et al.  Hysteroscopic and immunohistochemical findings in type I and type II endometrial carcinomas. , 2001, The Journal of the American Association of Gynecologic Laparoscopists.

[9]  F. al-Azzawi,et al.  Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial , 2000, The Lancet.

[10]  L. Dunkel,et al.  Apoptosis and apoptosis-related proteins in human endometrium , 2000, Molecular and Cellular Endocrinology.

[11]  O. Ceci,et al.  Hysteroscopic evaluation of menopausal patients with sonographically atrophic endometrium. , 1999, The Journal of the American Association of Gynecologic Laparoscopists.

[12]  M. Sauer,et al.  Utilizing routine sonohysterography to detect intrauterine pathology before initiating hormone replacement therapy. , 1999, Menopause.

[13]  S. Ascher,et al.  Endometrial Polyps: A Comparison Study of Patients Receiving Tamoxifen With Two Control Groups , 1998, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[14]  H. Maia,et al.  Comparison between suction curettage, transvaginal sonography and hysteroscopy for the diagnosis of endometrial polyp , 1998 .

[15]  P. Kubilis,et al.  Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium. , 1998, Annals of clinical and laboratory science.

[16]  A. Gompel,et al.  Bcl-2 expression in normal endometrium during the menstrual cycle. , 1994, The American journal of pathology.

[17]  G. Nuovo,et al.  Endometrial polyps in postmenopausal patients receiving tamoxifen. , 1989, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[18]  L. V. van Bogaert.  Clinicopathologic Findings in Endometrial Polyps , 1988, Obstetrics and gynecology.